Hicet-L Tablet contains Levocetirizine 5 mg, a third-generation non-sedative antihistamine used primarily for the relief of allergic symptoms. Levocetirizine is the active enantiomer of cetirizine and exhibits selective antagonism of peripheral H1 receptors, thereby inhibiting the effects of histamine, a key mediator in allergic reactions. This medication is indicated for the treatment of allergic rhinitis, including seasonal and perennial types, as well as chronic idiopathic urticaria characterized by symptoms such as sneezing, nasal congestion, rhinorrhea, itching, and hives. Hicet-L Tablet offers rapid onset of action with a favorable safety profile, minimizing central nervous system side effects commonly associated with first-generation antihistamines. It is administered orally, typically once daily, and is suitable for adults and children over six years of age, subject to physician guidance. Caution is advised in patients with renal impairment, and dosage adjustments may be necessary. Common adverse effects include headache, dry mouth, and fatigue, though these are generally mild and transient. Hicet-L Tablet should be used under medical supervision, particularly in individuals with pre-existing medical conditions or those taking concomitant medications to avoid potential drug interactions.